BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14661818)

  • 21. IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis.
    Vallinoto AC; Graça ES; Araújo MS; Azevedo VN; Cayres-Vallinoto I; Machado LF; Ishak MO; Ishak R
    Hum Immunol; 2010 Jul; 71(7):692-6. PubMed ID: 20353805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
    Xue S; Jia L; Jia J
    Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-γ +874T/A polymorphism increases susceptibility to post-traumatic osteomyelitis.
    Zhao XQ; Jiang N; Hu YJ; Yu B
    Int J Immunogenet; 2020 Apr; 47(2):163-168. PubMed ID: 31746120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of interferon-gamma, interleukin-4 and interleukin-17 single-nucleotide polymorphisms with susceptibility to tuberculosis.
    Mansouri F; Heydarzadeh R; Yousefi S
    APMIS; 2018 Mar; 126(3):227-233. PubMed ID: 29372577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
    Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
    Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
    Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotypic and allelic distribution of IFN-γ +874T/A and TGF-β1 -509C/T single-nucleotide polymorphisms in human  immunodeficiency virus-infected Thais.
    Akekawatchai C; Phuegsilp C; Changsri K; Soimanee T; Sretapunya W
    J Med Virol; 2022 Jun; 94(6):2882-2886. PubMed ID: 34981836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Association between Single Nucleotide Polymorphisms (SNPs) of the Interferon-Induced Transmembrane Protein 3 (
    Won SY; Kim YC; Jeong BH
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056363
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of Promoter Polymorphisms of Interleukin-10 and Interferon-Gamma Genes with Tuberculosis in Azeri Population of Iran.
    Asgharzadeh M; Ghorghanlu S; Rashedi J; Mahdavi Poor B; Khaki-Khatibi F; Moaddab SR; Samadi-Kafil H; Pourostadi M
    Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):167-73. PubMed ID: 27424131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dinucleotide repeat polymorphism in interferon-gamma gene is not associated with sporadic Alzheimer's disease.
    Oda M; Maruyama H; Izumi Y; Morino H; Torii T; Nakamura S; Kawakami H
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):48-9. PubMed ID: 14681912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease.
    Ciminelli BM; Menduti G; Benussi L; Ghidoni R; Binetti G; Squitti R; Rongioletti M; Nica S; Novelletto A; Rossi L; Malaspina P
    J Alzheimers Dis; 2020; 77(1):301-311. PubMed ID: 32804142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between late-onset Alzheimer's disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene.
    Wang LZ; Tian Y; Yu JT; Chen W; Wu ZC; Zhang Q; Zhang W; Tan L
    Neurosci Lett; 2011 Feb; 489(3):164-7. PubMed ID: 21163333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.